Cargando…
An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
The ability of clopidogrel (Plavix) to work in tandem with aspirin in a dual therapy strategy to boost the anti-platelet therapeutic impact and diminish platelet aggregation induced by platelet receptor inhibition is one of its many key advantages. The researchers discovered that the average reducti...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509004/ https://www.ncbi.nlm.nih.gov/pubmed/36171852 http://dx.doi.org/10.7759/cureus.28406 |